Quick recap
Growth strategy focused on China's infant milk formula market
Full-year results show double-digit revenue and earnings growth
China sales up 38%, record market share in China label IMFMarketing investment up 13% to $260m boosts
China brand healthTotal IMF sales rise 8% despite market decline of 14%
China IMF market decline due to fewer newborns and increased competition
Revenue grows 10.1% to $1,592.9 million with varied regional sales
EBITDA up 11.8% to $219.3 million
NPAT up 26.2% to $144.8 million
Earnings per share rise 28.7% to 21.2 cents
Company expects growth in FY24 despite market challenges.
- Forums
- ASX - By Stock
- A2M
- Ann: FY23 Annual Report
Ann: FY23 Annual Report, page-4
-
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$5.59 |
Change
-0.060(1.06%) |
Mkt cap ! $4.041B |
Open | High | Low | Value | Volume |
$5.67 | $5.68 | $5.58 | $14.79M | 2.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 38098 | $5.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.62 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 29294 | 5.580 |
1 | 3788 | 5.570 |
2 | 3656 | 5.560 |
8 | 10076 | 5.550 |
2 | 4500 | 5.520 |
Price($) | Vol. | No. |
---|---|---|
5.620 | 2000 | 1 |
5.640 | 479 | 1 |
5.650 | 7500 | 2 |
5.670 | 3039 | 1 |
5.700 | 19251 | 4 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online